Skip to main content
. 2020 Feb 26;6(2):e03488. doi: 10.1016/j.heliyon.2020.e03488

Table 2.

Association of KRAS gene mutation and RASSF1A aberrant promoter region methylation with the clinicopathological characteristics of NSCLC patients.

S.no Variables No. of Patients KRAS Mutation (Exon 2)
OR (95%CI) p value RASSF1A methylation status
OR (95%CI) p value
Positive n (%) Negative n (%) No. of methylated samples n (%) No. of Unmethylated samples n (%)
1. Age at Diagnosis

≤45Y 13 3 (23.08) 10 (76.92) 0.632 (0.120–3.329) 0.58 3 (23.08) 10 (76.92) 0.824 (0.261–2.589) 0.13
>45Y 87 28 (32.18) 59 (67.82) 1 38 (43.67) 49 (56.33) 1

2. Gender

Male 68 26 (38.23) 42 (61.77) 0.970 (0.327–2.873) 0.95 30 (44.11) 38 (55.89) 0.540 (0.130–2.145) 0.60
Female 32 5 (15.62) 27 (84.38) 1 11 (34.37) 21 (65.63) 1

3. Histological Type

Adenocarcinoma 72 21 (29.16) 51 (70.84) 0.811 (0.257–2.588) 0.01∗ 34 (47.22) 38 (52.78) 0.621 (0.157–2.183) 0.03∗
Squamous Cell
Carcinoma
28 10 (35.71) 18 (64.29) 1 7 (25) 21 (75) 1

4. Smoking Status

Smokers 62 25 (40.32) 37 (59.68) 4.899 (1.273–18.77) 0.01∗ 32 (51.61) 30 (48.39) 3.099 (1.167–4.443) 0.01∗
Non smokers 38 6 (15.78) 32 (84.22) 1 9 (23.68) 29 (76.32) 1
Current smokers 20 6 (30) 14 (70) 0.182 (0.047–0.697) 0.01∗ 12 (60) 8 (40) 0.282 (0.036–0.856) 0.03∗
Ex-smokers 42 19 (45.23) 23 (54.77) 1 20 (47.61) 22 (52.39) 1

5. TNM Staging

Early stage (I and II) 53 11 (20.75) 42 (79.25) 0.353 (0.112–1.116) 0.05∗ 11 (20.75) 42 (79.25) 0.359 (0.114–1.129) 0.05∗
Advanced Stage (III and IV) 47 20 (42.55) 27 (57.45) 1 30 (63.82) 17 (36.18) 1

6. Distant Metastasis

Positive 18 06 (33.33) 12 (66.67) 0.941 (0.319–2.775) 0.03∗ 10 (55.55) 08 (44.45) 0.821 (0.289–2.786) 0.02∗
Negative 82 25 (30.48) 57 (69.52) 1 31 (37.80) 51 (62.20) 1

7. Smoking Level

Mild (≤10) 5 03 (60.00) 02 (40.00) 1 0.64 0 (0.00) 05 (100) 1 0.72
Moderate (≤40) 30 12 (40) 18 (60) 0.550 (0.043–7.034) 16 (53.33) 14 (46.67) 0.460 (0.023–7.045)
Heavy (>40) 27 10 (37.03) 17 (62.97) 0.308 (0.024–3.968) 0.34 18 (67.66) 9 (32.34) 0.209 (0.014–3.799) 0.22
No-smoking 38 6 (15.78) 32 (84.22) 1 7 (18.42) 31 (81.58) 1

∗ significant (p < 0.05).